Details for New Drug Application (NDA): 205512
✉ Email this page to a colleague
The generic ingredient in RANITIDINE HYDROCHLORIDE is ranitidine hydrochloride. There are forty-three drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the ranitidine hydrochloride profile page.
Summary for 205512
Tradename: | RANITIDINE HYDROCHLORIDE |
Applicant: | Strides Pharma |
Ingredient: | ranitidine hydrochloride |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 150MG BASE | ||||
Approval Date: | Aug 22, 2016 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 300MG BASE | ||||
Approval Date: | Aug 22, 2016 | TE: | RLD: | No |
Complete Access Available with Subscription